Crescent Capital BDC, Inc. (NASDAQ: FCRX) operates as an externally managed business development company focused on originating and investing in debt and equity securities of private U.S. middle-market companies; its portfolio primarily comprises senior secured first lien loans (approximately 65%), unitranche loans, second lien loans, and subordinated debt, with equity co-investments in select cases; the company targets sectors including healthcare, technology, consumer products, business services, and industrials, serving sponsored and non-sponsored borrowers with strong credit profiles across approximately 187-191 portfolio companies valued at over $1.6 billion as of mid-2025. Founded in 2015 and headquartered in Los Angeles, California, Crescent Capital BDC, Inc. is managed by affiliates of Crescent Capital Group LP, which leverages over two decades of experience in private credit to deliver customized financing solutions regulated under the Investment Company Act of 1940. Recent developments include robust quarterly earnings releases through 2025, with Q3 2025 results showing a stable portfolio, declaration of a $0.42 per share base dividend plus a final $0.05 special dividend, and authorization of a $20 million stock repurchase program; the company deployed $104.7 million in new investments across 10 portfolio companies in Q1 2025 while achieving $78 million in exits, maintaining strong liquidity with $26.1 million in cash and $227.2 million undrawn credit; its investment vehicle, 5.00% Notes due 2026 (FCRX), trades actively on public markets.